BTAI - BioXcel regains compliance with Nasdaq listing rule
2025-09-18 07:41:38 ET
More on BioXcel Therapeutics
- BioXcel Therapeutics, Inc. (BTAI) Discuses On SERENITY At-Home Pivotal Phase 3 Safety Trial Results Call (Transcript)
- BioXcel Therapeutics, Inc. (BTAI) Discuses On SERENITY At-Home Pivotal Phase 3 Safety Trial Results Call - Slideshow
- BioXcel whipsaws after late-stage trial win for lead asset
- Seeking Alpha’s Quant Rating on BioXcel Therapeutics
- Historical earnings data for BioXcel Therapeutics